BRCA1, hormone, and tissue-specific tumor suppression
- PMID: 19119312
- PMCID: PMC2605575
- DOI: 10.7150/ijbs.5.20
BRCA1, hormone, and tissue-specific tumor suppression
Abstract
Germline mutations of BRCA1 predispose women to breast and ovarian cancers. Elucidating molecular mechanism of tissue- and gender-specific phenomena in BRCA1-related tumors is a key to our understanding of BRCA1 function in tumor suppression. This review summarizes studies in recent years on the link between BRCA1 and estrogen/progesterone signaling pathways, as well as discusses various models underscoring a triangle relationship among BRCA1, estrogen and genome instability.
Keywords: BRCA1; estrogen; genome instability.; tumor suppression.
Conflict of interest statement
Conflict of Interest: The author has declared that no conflict of interest exists.
Figures


Similar articles
-
Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.Genes Chromosomes Cancer. 2004 Mar;39(3):236-48. doi: 10.1002/gcc.10321. Genes Chromosomes Cancer. 2004. PMID: 14732925
-
Epigenetic changes in BRCA1-mutated familial breast cancer.Cancer Genet. 2015 May;208(5):237-40. doi: 10.1016/j.cancergen.2015.02.001. Epub 2015 Feb 13. Cancer Genet. 2015. PMID: 25800897 Free PMC article. Review.
-
miRNA expression patterns in normal breast tissue and invasive breast cancers of BRCA1 and BRCA2 germ-line mutation carriers.Oncotarget. 2015 Oct 13;6(31):32115-37. doi: 10.18632/oncotarget.5617. Oncotarget. 2015. PMID: 26378051 Free PMC article.
-
BRCA1 deficiency exacerbates estrogen-induced DNA damage and genomic instability.Cancer Res. 2014 May 15;74(10):2773-2784. doi: 10.1158/0008-5472.CAN-13-2611. Epub 2014 Mar 17. Cancer Res. 2014. PMID: 24638981 Free PMC article.
-
BRCA1: the enigma of tissue-specific tumor development.Trends Genet. 2003 Jun;19(6):312-5. doi: 10.1016/S0168-9525(03)00110-0. Trends Genet. 2003. PMID: 12801723 Review.
Cited by
-
Drug repurposing screen identifies lestaurtinib amplifies the ability of the poly (ADP-ribose) polymerase 1 inhibitor AG14361 to kill breast cancer associated gene-1 mutant and wild type breast cancer cells.Breast Cancer Res. 2014 Jun 24;16(3):R67. doi: 10.1186/bcr3682. Breast Cancer Res. 2014. PMID: 24962108 Free PMC article.
-
BRCA1/BARD1 complex interacts with steroidogenic factor 1--A potential mechanism for regulation of aromatase expression by BRCA1.J Steroid Biochem Mol Biol. 2011 Jan;123(1-2):71-8. doi: 10.1016/j.jsbmb.2010.11.006. Epub 2010 Nov 16. J Steroid Biochem Mol Biol. 2011. PMID: 21087664 Free PMC article.
-
Assessing estrogen signaling aberrations in breast cancer risk using genetically engineered mouse models.Ann N Y Acad Sci. 2011 Jul;1229(1):147-55. doi: 10.1111/j.1749-6632.2011.06086.x. Ann N Y Acad Sci. 2011. PMID: 21793850 Free PMC article. Review.
-
BRCA1 affects global DNA methylation through regulation of DNMT1.Cell Res. 2010 Nov;20(11):1201-15. doi: 10.1038/cr.2010.128. Epub 2010 Sep 7. Cell Res. 2010. PMID: 20820192 Free PMC article.
-
RANKL/RANK: from bone loss to the prevention of breast cancer.Open Biol. 2016 Nov;6(11):160230. doi: 10.1098/rsob.160230. Open Biol. 2016. PMID: 27881737 Free PMC article. Review.
References
-
- Hall J.M et al. Linkage of Early-Onset Familial Breast Cancer to Chromosome 17q21. Science. 1990;250:1684–1689. - PubMed
-
- Miki Y et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266(5182):66–71. - PubMed
-
- Zheng L et al. Lessons learned from BRCA1 and BRCA2. Oncogene. 2000;19(53):6159–75. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous